Department of Occupational Therapy, New York University, New York, NY, USA/Kessler Foundation, West Orange, NJ, USA.
The University of Texas Southwestern Medical Center, Dallas, TX, USA.
Mult Scler. 2023 Aug;29(9):1107-1117. doi: 10.1177/13524585231185048. Epub 2023 Jul 26.
There is considerable evidence that persons with multiple sclerosis (PwMS) who experience cognitive impairments (CIs) are at risk of having significant limitations in activities of daily living (ADLs). However, ADL assessment often consists of proxies or self-report of ADLs. This study examined whether the performance of instrumental ADLs (I-ADL) is impaired in PwMS with and without CI.
Participants included 72 PwMS and 48 matched healthy controls (HCs). PwMS were divided into MS-CI ( = 25) and MS-not-impaired ( = 47) groups based on the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) scores. All participants performed the Actual Reality (AR) test, measuring I-ADL using authentic websites.
The MS-CI performed significantly worse on AR compared with HC and MS-not-impaired. In addition, the MS-not-impaired performed significantly worse than HC on AR. AR differentiates well between PwMS with and without CI.
While CI in MS results in significant limitations in the performance of I-ADL, PwMS who do not show evidence of CI can have limitations in I-ADL. AR assessment is a valid and reliable tool sensitive to CI. It should be used in addition to traditional cognitive assessments to detect early functional deterioration through the course of MS.
有大量证据表明,患有多发性硬化症(MS)且认知受损(CI)的患者日常生活活动(ADL)会受到严重限制。然而,ADL 的评估通常由 ADL 的代理人或自我报告组成。本研究旨在探究是否患有 CI 和无 CI 的多发性硬化症患者在工具性日常生活活动(I-ADL)方面存在表现障碍。
参与者包括 72 名多发性硬化症患者和 48 名匹配的健康对照组(HCs)。根据简短国际认知评估多发性硬化症量表(BICAMS)评分,将多发性硬化症患者分为多发性硬化症伴有认知障碍(MS-CI)组(n=25)和多发性硬化症无认知障碍(MS-not-impaired)组(n=47)。所有参与者均进行实际现实(AR)测试,通过真实网站来测量 I-ADL。
与 HC 和 MS-not-impaired 相比,MS-CI 在 AR 上的表现明显更差。此外,MS-not-impaired 在 AR 上的表现也明显比 HC 差。AR 能很好地区分有和无 CI 的多发性硬化症患者。
多发性硬化症导致 CI 患者在 I-ADL 的表现上存在严重限制,而没有 CI 证据的多发性硬化症患者可能在 I-ADL 方面存在限制。AR 评估是一种敏感的、有效的和可靠的工具,可用于评估 CI。它应该与传统的认知评估相结合,以在多发性硬化症的病程中通过早期功能恶化来检测 CI。